PropertyValue
?:abstract
  • SARS-CoV-2 is a new pandemic virus for which Remdesivir is the only antiviral available. We report the occurrence of a mutation in the RdRP (D484Y) following failure of remdesivir in a 76-year-old woman with a post-rituximab B-cell immunodeficiency and persistent SARS-CoV-2 viremia. Cure was reached after supplementation with convalescent plasma.
?:creator
?:doi
  • 10.1093/cid/ciaa1474
?:doi
?:journal
  • Clin_Infect_Dis
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/c16174fa6387303fb049ccc642a171fc676eb2c0.json
?:pmcid
?:pmid
?:pmid
  • 32986807.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Remdesivir failure with SARS-CoV-2 RNA-dependent RNA-polymerase mutation in a B-cell immunodeficient patient with protracted Covid-19
?:type
?:year
  • 2020-09-28

Metadata

Anon_0  
expand all